You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 4, April 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Bromocriptine and CF 25-397 in the Treatment of Tardive Dyskinesia

Carol A. Tamminga, MD; Thomas N. Chase, MD

Arch Neurol. 1980;37(4):204-205.


Abstract

• Dopamine agonist therapy using se lected drugs at particular dosage levels has been found to have therapeutic benefit in certain dyskinetic syndromes. Two ergot derivatives with dopamine agonist properties were administered at relatively low doses to eight neuroleptic-free schizophrenic patients with tardive dyskinesia. Neither agent significantly improved dyskinetic symptoms; no symptoms worsened. Dopamine agonists likely vary in their selective activation of functionally distinct dopamine receptors.



Author Affiliations

From the Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD.


Footnotes

Accepted for publication April 20, 1979.

Reprint requests to Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20205 (Dr Tamminga).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Tardive Dyskinesia With Bromocriptine: A Test of the Receptor Modification Strategy
Lieberman et al.
Arch Gen Psychiatry 1989;46:908-913.
ABSTRACT  

Drugs Five Years Later: Bromocriptine
VANCE et al.
ANN INTERN MED 1984;100:78-91.
ABSTRACT  

Is Bromocriptine a Dopamine Antagonist Treatment?
Lieberman et al.
Arch Gen Psychiatry 1983;40:469-470.
ABSTRACT  

Is Bromocriptine a Dopamine Antagonist Treatment?-Reply
Jeste and Wyatt
Arch Gen Psychiatry 1983;40:470-470.
ABSTRACT  

Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience
Jeste and Jed Wyatt
Arch Gen Psychiatry 1982;39:803-816.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.